CDK4 and breast carcinoma: Single-cell data for ER+ breast cancer treated with CDK4/6 inhibitors combined with endocrine therapy were sourced from GSE158724 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158724).